BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu LH, King KL, Loong CC, Hsia CY, Chi CW. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg. 2000;231:552-558. [PMID: 10749617 DOI: 10.1097/00000658-200004000-00015] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Li B, Su H, Cao J, Zhang L. CXCL13 rather than IL-31 is a potential indicator in patients with hepatocellular carcinoma. Cytokine 2017;89:91-7. [PMID: 27663978 DOI: 10.1016/j.cyto.2016.08.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
2 Sullivan KM, Kenerson HL, Pillarisetty VG, Riehle KJ, Yeung RS. Precision oncology in liver cancer. Ann Transl Med 2018;6:285. [PMID: 30105235 DOI: 10.21037/atm.2018.06.14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
3 Mohran ZY, Ali-Eldin FA, Abdel Aal HA. Serum interleukin-18: does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma? Arab J Gastroenterol. 2011;12:29-33. [PMID: 21429452 DOI: 10.1016/j.ajg.2010.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zekri AR, Ashour MS, Hassan A, Alam El-Din HM, El-Shehaby AM, Abu-Shady MA. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression. World J Gastroenterol. 2005;11:6624-6630. [PMID: 16425355 DOI: 10.3748/wjg.v11.i42.6624] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
6 Yanaga K, Okudaira S, Kanematsu T, Marsh JW. Hepatic Resection for Hepatocellular Carcinoma. In: Carr BI, editor. Hepatocellular Cancer. Totowa: Humana Press; 2005. pp. 185-98. [DOI: 10.1007/978-1-59259-844-1_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Llopiz D, Ruiz M, Silva L, Sarobe P. Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10. Front Immunol 2018;9:1923. [PMID: 30233565 DOI: 10.3389/fimmu.2018.01923] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chen W, Chau G, Lui W, Tsay S, King K, Loong C, Wu C. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. European Journal of Surgical Oncology (EJSO) 2004;30:414-20. [DOI: 10.1016/j.ejso.2004.01.013] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 4.7] [Reference Citation Analysis]
9 Wu L, Zhou L, Xu J, Wei B, Cheng J, Xu X, Xi B, Xie H, Zheng S. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation. Hepatobiliary & Pancreatic Diseases International 2013;12:54-9. [DOI: 10.1016/s1499-3872(13)60006-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 2002;8:385-392. [PMID: 12046056 DOI: 10.3748/wjg.v8.i3.385] [Cited by in CrossRef: 205] [Cited by in F6Publishing: 191] [Article Influence: 10.8] [Reference Citation Analysis]
11 Yeh CT, So M, Ng J, Yang HW, Chang ML, Lai MW, Chen TC, Lin CY, Yeh TS, Lee WC. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology. 2010;52:1922-1933. [PMID: 20814897 DOI: 10.1002/hep.23898] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 5.2] [Reference Citation Analysis]
12 Cariani E, Missale G. Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications. Liver Int. 2019;39:1608-1621. [PMID: 31314948 DOI: 10.1111/liv.14192] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
13 La Rosa C, Limaye AP, Krishnan A, Blumstein G, Longmate J, Diamond DJ. Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients. Transpl Int. 2011;24:920-931. [PMID: 21672050 DOI: 10.1111/j.1432-2277.2011.01285.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
14 Li W, Dong H, Huang Y, Chen T, Kong X, Sun H, Yu X, Xu J. Clonorchis sinensis Co-infection Could Affect the Disease State and Treatment Response of HBV Patients. PLoS Negl Trop Dis 2016;10:e0004806. [PMID: 27348302 DOI: 10.1371/journal.pntd.0004806] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
15 Takeichi T, Engelmann G, Mocevicius P, Schmidt J, Ryschich E. 4-Dimensional Intravital Microscopy: A New Model for Studies of Leukocyte Recruitment and Migration in Hepatocellular Cancer in Mice. J Gastrointest Surg 2010;14:867-72. [DOI: 10.1007/s11605-010-1179-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
16 Omura Y, Toiyama Y, Okugawa Y, Yin C, Shigemori T, Kusunoki K, Kusunoki Y, Ide S, Shimura T, Fujikawa H, Yasuda H, Hiro J, Ohi M, Kusunoki M. Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients. Cancer Immunol Immunother 2020;69:2533-46. [PMID: 32577816 DOI: 10.1007/s00262-020-02645-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 2005;78:1043-1051. [PMID: 16204623 DOI: 10.1189/jlb.0705358] [Cited by in Crossref: 254] [Cited by in F6Publishing: 236] [Article Influence: 15.9] [Reference Citation Analysis]
18 Sheng T, Wang B, Wang SY, Deng B, Qu L, Qi XS, Wang XL, Deng GL, Sun X. The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection. Medicine (Baltimore). 2015;94:e941. [PMID: 26091457 DOI: 10.1097/MD.0000000000000941] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
19 Zhou YM, Zhang XF, Li B, Sui CJ, Yang JM. Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection. BMC Cancer 2015;15:689. [PMID: 26466573 DOI: 10.1186/s12885-015-1720-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
20 Li CP, Huang TS, Chao Y, Chang FY, Whang-Peng J, Lee SD. Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies. World J Gastroenterol. 2004;10:2468-2471. [PMID: 15300886 DOI: 10.3748/wjg.v10.i17.2468] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
21 Chan SL, Mo FK, Wong CS, Chan CM, Leung LK, Hui EP, Ma BB, Chan AT, Mok TS, Yeo W. A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma. Cancer. 2012;118:3984-3992. [PMID: 22180222 DOI: 10.1002/cncr.26726] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
22 Faupel-Badger JM, Kidd LC, Albanes D, Virtamo J, Woodson K, Tangrea JA. Association of IL-10 polymorphisms with prostate cancer risk and grade of disease. Cancer Causes Control 2008;19:119-24. [PMID: 17999153 DOI: 10.1007/s10552-007-9077-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
23 Pleguezuelo M, Germani G, Marelli L, Xiruochakis E, Misseri M, Manousou P, Arvaniti V, Burroughs AK. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;2:761-84. [DOI: 10.1586/17474124.2.6.761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
24 Novikova MV, Khromova NV, Kopnin PB. Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression. Biochemistry (Mosc) 2017;82:861-73. [PMID: 28941454 DOI: 10.1134/S0006297917080016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
25 Galizia G, Lieto E, De Vita F, Romano C, Orditura M, Castellano P, Imperatore V, Infusino S, Catalano G, Pignatelli C. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome. J Interferon Cytokine Res. 2002;22:473-482. [PMID: 12034030 DOI: 10.1089/10799900252952262] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
26 Lausted C, Hu Z, Hood L. Quantitative serum proteomics from surface plasmon resonance imaging. Mol Cell Proteomics. 2008;7:2464-2474. [PMID: 18678562 DOI: 10.1074/mcp.m800121-mcp200] [Cited by in Crossref: 60] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
27 Cai H, Zhang Y, Meng F, Cui C, Li H, Sui M, Zhang H, Lu S. Preoperative Serum IL6, IL8, and TNF-α May Predict the Recurrence of Hepatocellular Cancer. Gastroenterol Res Pract 2019;2019:6160783. [PMID: 31781194 DOI: 10.1155/2019/6160783] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Chiang CL, Kandalaft LE, Tanyi J, Hagemann AR, Motz GT, Svoronos N, Montone K, Mantia-Smaldone GM, Smith L, Nisenbaum HL, Levine BL, Kalos M, Czerniecki BJ, Torigian DA, Powell DJ Jr, Mick R, Coukos G. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clin Cancer Res 2013;19:4801-15. [PMID: 23838316 DOI: 10.1158/1078-0432.CCR-13-1185] [Cited by in Crossref: 123] [Cited by in F6Publishing: 71] [Article Influence: 15.4] [Reference Citation Analysis]
29 Zhao S, Wu D, Wu P, Wang Z, Huang J. Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLoS One. 2015;10:e0139598. [PMID: 26440936 DOI: 10.1371/journal.pone.0139598] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
30 Qin LX, Tang ZY. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol. 2004;130:497-513. [PMID: 15205947 DOI: 10.1007/s00432-004-0572-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 123] [Article Influence: 6.2] [Reference Citation Analysis]
31 Othman MS, Aref AM, Mohamed AA, Ibrahim WA. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients. ISRN Hepatol 2013;2013:412317. [PMID: 27335826 DOI: 10.1155/2013/412317] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
32 Gelu-Simeon M, Samuel D. Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma. Hepatol Int 2013;7:788-91. [PMID: 26201913 DOI: 10.1007/s12072-013-9441-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Eur J Surg Oncol. 2007;33:208-212. [PMID: 17140760 DOI: 10.1016/j.ejso.2006.10.036] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
34 Hsu HY, Yu MC, Lee CW, Tsai HI, Sung CM, Chen CW, Huang SW, Lin CY, Jeng WJ, Lee WC, Chen MF. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma. BMC Cancer. 2017;17:742. [PMID: 29121890 DOI: 10.1186/s12885-017-3748-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
35 Yoon SK. Recent advances in tumor markers of human hepatocellular carcinoma. Intervirology. 2008;51 Suppl 1:34-41. [PMID: 18544946 DOI: 10.1159/000122596] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
36 Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, Terranova A, Cervello M, D'Alessandro N, Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol 2006;12:2563-8. [PMID: 16688802 DOI: 10.3748/wjg.v12.i16.2563] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
37 Kawabata T, Ichikura T, Majima T, Seki S, Chochi K, Takayama E, Hiraide H, Mochizuki H. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer 2001;92:2050-5. [DOI: 10.1002/1097-0142(20011015)92:8<2050::aid-cncr1544>3.0.co;2-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
38 Murayama H, Ikemoto M, Fukuda Y, Tsunekawa S, Nagata A. Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells. Clin Chim Acta 2007;380:170-4. [PMID: 17350606 DOI: 10.1016/j.cca.2007.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
39 Ikeguchi M, Hatada T, Yamamoto M, Miyake T, Matsunaga T, Fukumoto Y, Yamada Y, Fukuda K, Saito H, Tatebe S. Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer. 2009;12:95-100. [PMID: 19562463 DOI: 10.1007/s10120-009-0509-8] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
40 Limaye AP, La Rosa C, Longmate J, Diamond DJ. Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients. Transplantation 2016;100:210-6. [PMID: 26680375 DOI: 10.1097/TP.0000000000000816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
41 Martinez EF, Napimoga MH, Montalli VAM, de Araújo NS, de Araújo VC. In vitro cytokine expression in in situ-like areas of malignant neoplasia. Archives of Oral Biology 2013;58:552-7. [DOI: 10.1016/j.archoralbio.2012.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
42 Zhao W, Su W, Kuang P, Zhang L, Liu J, Yin Z, Wang X. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma. Int J Oncol. 2012;41:457-464. [PMID: 22641338 DOI: 10.3892/ijo.2012.1497] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
43 LE PH, Huang SC, Lim SN, Chou CH, Yeh TS, Chen TC, Yen TH, Su MY, Chiu CT, Yeh CT, Lin WR. Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma. Oncol Lett 2014;7:1430-8. [PMID: 24765151 DOI: 10.3892/ol.2014.1966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
44 Zhang Y, Zhang B, Zhang A, Li X, Liu J, Zhao J, Zhao Y, Gao J, Fang D, Rao Z. IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells. Braz J Med Biol Res 2013;46:32-8. [PMID: 23011405 DOI: 10.1590/s0100-879x2012007500155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
45 Ebrahim M, Bagheri V, Arababadi MK. Potential roles played by IL-6 in hepatitis B infection. Future Virology 2014;9:431-8. [DOI: 10.2217/fvl.14.21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
46 Garcia-cruz A, Lee M, Zine N, Sigaud M, Bausells J, Errachid A. Poly(pyrrole) microwires fabrication process on flexible thermoplastics polymers: Application as a biosensing material. Sensors and Actuators B: Chemical 2015;221:940-50. [DOI: 10.1016/j.snb.2015.06.084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
47 Llopiz D, Ruiz M, Infante S, Villanueva L, Silva L, Hervas-Stubbs S, Alignani D, Guruceaga E, Lasarte JJ, Sarobe P. IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination. Oncotarget 2017;8:2659-71. [PMID: 27926522 DOI: 10.18632/oncotarget.13736] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
48 Chau GY. Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome. World J Gastroenterol. 2014;20:12473-12484. [PMID: 25253947 DOI: 10.3748/wjg.v20.i35.12473] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
49 Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, Terranova A, Cervello M, D'Alessandro N, Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol. 2006;12:2563-2568. [PMID: 16688802 DOI: 10.3748/wjg.v12.i16] [Reference Citation Analysis]
50 Qian Q, Wu C, Chen J, Wang W. Relationship between IL10 and PD-L1 in Liver Hepatocellular Carcinoma Tissue and Cell Lines. Biomed Res Int. 2020;2020:8910183. [PMID: 32724815 DOI: 10.1155/2020/8910183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Aroucha D, do Carmo R, Moura P, Silva J, Vasconcelos L, Cavalcanti M, Muniz M, Aroucha M, Siqueira E, Cahú G, Pereira L, Coêlho M. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C. Cytokine 2013;62:421-5. [DOI: 10.1016/j.cyto.2013.03.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
52 Chen L, Zhang Q, Chang W, Du Y, Zhang H, Cao G. Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma. European Journal of Cancer 2012;48:1977-87. [DOI: 10.1016/j.ejca.2012.01.015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 7.1] [Reference Citation Analysis]
53 Saleh R, Elkord E. FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets. Cancer Lett 2020;490:174-85. [PMID: 32721551 DOI: 10.1016/j.canlet.2020.07.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 25.0] [Reference Citation Analysis]
54 Uemura A, Takehara T, Miyagi T, Suzuki T, Tatsumi T, Ohkawa K, Kanto T, Hiramatsu N, Hayashi N. Natural killer cell is a major producer of interferon gamma that is critical for the IL-12-induced anti-tumor effect in mice. Cancer Immunol Immunother. 2010;59:453-463. [PMID: 19756594 DOI: 10.1007/s00262-009-0764-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
55 Duda DG, Dima SO, Cucu D, Sorop A, Klein S, Ancukiewicz M, Kitahara S, Iacob S, Bacalbasa N, Tomescu D, Herlea V, Tanase C, Croitoru A, Popescu I. Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients. Cancers (Basel) 2020;12:E1275. [PMID: 32443546 DOI: 10.3390/cancers12051275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
56 Bien E, Balcerska A, Adamkiewicz-Drozynska E, Rapala M, Krawczyk M, Stepinski J. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias. Clin Biochem 2009;42:1144-57. [PMID: 19376105 DOI: 10.1016/j.clinbiochem.2009.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
57 Hassuneh MR, Nagarkatti M, Nagarkatti PS. Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma. Leuk Lymphoma 2013;54:827-34. [PMID: 22946665 DOI: 10.3109/10428194.2012.726721] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
58 Hatab HM, Abdel Hamid FF, Soliman AF, Al-Shafie TA, Ismail YM, El-Houseini ME. A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study. J Gastrointest Oncol 2019;10:766-76. [PMID: 31392057 DOI: 10.21037/jgo.2019.03.07] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
59 Shakiba E, Ramezani M, Sadeghi M. Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis. Clin Exp Hepatol 2018;4:35-40. [PMID: 29594196 DOI: 10.5114/ceh.2018.73484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Liu T, Wu H, Qi J, Qin C, Zhu Q. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma. Cancer Med 2020;9:7440-52. [PMID: 32815653 DOI: 10.1002/cam4.3406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
61 R, Agnihotri N, Singh AP, Bhatnagar A. Involvement of Regulatory T Cells and Their Cytokines Repertoire in Chemopreventive Action of Fish Oil in Experimental Colon Cancer. Nutrition and Cancer 2016;68:1181-91. [DOI: 10.1080/01635581.2016.1212245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
62 Kim MJ, Jang JW, Oh BS, Kwon JH, Chung KW, Jung HS, Jekarl DW, Lee S. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma. Cytokine. 2013;64:516-522. [PMID: 24035756 DOI: 10.1016/j.cyto.2013.07.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
63 Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. Regulation of adaptive immunity; the role of interleukin-10. Front Immunol. 2013;4:129. [PMID: 23755052 DOI: 10.3389/fimmu.2013.00129] [Cited by in Crossref: 119] [Cited by in F6Publishing: 146] [Article Influence: 14.9] [Reference Citation Analysis]
64 Lai MW, Huang SF, Lin SM, Chen TC, Lin CY, Yeh CN, Yeh TS, Chen MF, Yeh CT. Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res 2009;39:164-76. [PMID: 19208037 DOI: 10.1111/j.1872-034X.2008.00413.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
65 Sun L, Lin Z, Duan X, Qi H, Yang N, Li M, Xing E, Sun Y, Yu M, Li W, Lu J. Suppression of the Production of Transforming Growth Factor β1, Interleukin-10, and Vascular Endothelial Growth Factor in the B16F10 Cells by Ganoderma lucidum Polysaccharides. Journal of Interferon & Cytokine Research 2014;34:667-75. [DOI: 10.1089/jir.2012.0101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
66 Galizia G, Orditura M, Romano C, Lieto E, Castellano P, Pelosio L, Imperatore V, Catalano G, Pignatelli C, De Vita F. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 2002;102:169-78. [PMID: 11846459 DOI: 10.1006/clim.2001.5163] [Cited by in Crossref: 142] [Cited by in F6Publishing: 126] [Article Influence: 7.5] [Reference Citation Analysis]
67 Ye Z, Shi M, Chan T, Sas S, Xu S, Xiang J. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors. Cancer Gene Ther 2007;14:661-75. [PMID: 17479109 DOI: 10.1038/sj.cgt.7701039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
68 Chen VL, Le AK, Podlaha O, Estevez J, Li B, Vutien P, Chang ET, Rosenberg-Hasson Y, Pflanz S, Jiang Z, Ge D, Gaggar A, Nguyen MH. Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers. Sci Rep. 2017;7:11169. [PMID: 28894136 DOI: 10.1038/s41598-017-10498-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
69 Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009;125:2264-2269. [PMID: 19585572 DOI: 10.1002/ijc.24720] [Cited by in Crossref: 114] [Cited by in F6Publishing: 110] [Article Influence: 9.5] [Reference Citation Analysis]
70 Takeichi T, Mocevicius P, Deduchovas O, Salnikova O, Castro-Santa E, Büchler MW, Schmidt J, Ryschich E. αL β2 integrin is indispensable for CD8+ T-cell recruitment in experimental pancreatic and hepatocellular cancer. Int J Cancer 2012;130:2067-76. [PMID: 21647874 DOI: 10.1002/ijc.26223] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
71 Cho HJ, Kim SS, Ahn SJ, Park SY, Park JH, Kim JK, Wang HJ, Cheong JY, Cho SW. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. Cytokine. 2015;73:245-252. [PMID: 25797190 DOI: 10.1016/j.cyto.2015.02.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
72 Toiyama Y, Miki C, Inoue Y, Minobe S, Urano H, Kusunoki M. Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surg Today. 2010;40:46-53. [PMID: 20037839 DOI: 10.1007/s00595-009-4016-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
73 Qu F, Li R, He X, Li Q, Xie S, Gong L, Ji G, Lu J, Bao G. Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients. Mol Oncol 2015;9:727-39. [PMID: 25515040 DOI: 10.1016/j.molonc.2014.11.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
74 Tangkijvanich P, Thong-Ngam D, Mahachai V, Theamboonlers A, Poovorawan Y. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma. World J Gastroenterol. 2007;13:4345-4349. [PMID: 17708609 DOI: 10.3748/wjg.v13.i32.4345] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
75 Chau GY, Lui WY, Wu CW. Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:25-34, viii. [PMID: 12735127 DOI: 10.1016/s1055-3207(02)00077-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
76 Mahipal A, Terai M, Berd D, Chervoneva I, Patel K, Mastrangelo MJ, Sato T. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine. Cancer Immunol Immunother 2011;60:1039-45. [DOI: 10.1007/s00262-011-1019-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
77 Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, Krause M, Schwörer AM, Wagner U, Müller-Brüsselbach S, Müller R. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer 2014;134:32-42. [PMID: 23784932 DOI: 10.1002/ijc.28335] [Cited by in Crossref: 136] [Cited by in F6Publishing: 131] [Article Influence: 17.0] [Reference Citation Analysis]
78 Andreana L, Isgrò G, Pleguezuelo M, Germani G, Burroughs AK. Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World J Hepatol 2009;1:48-61. [PMID: 21160965 DOI: 10.4254/wjh.v1.i1.48] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
79 Walker WH 2nd, Borniger JC. Molecular Mechanisms of Cancer-Induced Sleep Disruption. Int J Mol Sci 2019;20:E2780. [PMID: 31174326 DOI: 10.3390/ijms20112780] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
80 Shakiba E, Ramezani M, Sadeghi M. Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis. Clin Exp Hepatol 2018;4:182-90. [PMID: 30324143 DOI: 10.5114/ceh.2018.78122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
81 Saied A, Pillarisetty VG, Katz SC. Immunotherapy for solid tumors--a review for surgeons. J Surg Res 2014;187:525-35. [PMID: 24485876 DOI: 10.1016/j.jss.2013.12.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
82 Tang TJ, Vukosavljevic D, Janssen HL, Binda RS, Mancham S, Tilanus HW, Ijzermans JN, Drexhage H, Kwekkeboom J. Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma. Hum Pathol. 2006;37:332-338. [PMID: 16613328 DOI: 10.1016/j.humpath.2005.11.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
83 Jang JW, Oh BS, Kwon JH, You CR, Chung KW, Kay CS, Jung HS. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. Cytokine. 2012;60:686-693. [PMID: 22906998 DOI: 10.1016/j.cyto.2012.07.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 7.2] [Reference Citation Analysis]
84 Lee I, Huang Y, Chau G, Huo T, Su C, Wu J, Lin H. Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments: Interferon-gamma and HCC. Int J Cancer 2013. [DOI: 10.1002/ijc.28311] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
85 Ariyasu T, Tanaka T, Fujioka N, Yanai Y, Yamamoto S, Yamauchi H, Ikegami H, Ikeda M, Kurimoto M. Effects of interferon-alpha subtypes on the TH1/TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders. In Vitro Cell Dev Biol Anim. 2005;41:50-56. [PMID: 15926860 DOI: 10.1290/0501008.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
86 Waller EK, Ernstoff MS. Modulation of antitumor immune responses by hematopoietic cytokines. Cancer. 2003;97:1797-1809. [PMID: 12655538 DOI: 10.1002/cncr.11247] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
87 De Vita F, Romano C, Orditura M, Galizia G, Martinelli E, Lieto E, Catalano G. Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res 2001;21:45-52. [PMID: 11177580 DOI: 10.1089/107999001459150] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 3.1] [Reference Citation Analysis]
88 Chew V, Chen J, Lee D, Loh E, Lee J, Lim KH, Weber A, Slankamenac K, Poon RT, Yang H, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Abastado JP. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut. 2012;61:427-438. [PMID: 21930732 DOI: 10.1136/gutjnl-2011-300509] [Cited by in Crossref: 192] [Cited by in F6Publishing: 176] [Article Influence: 19.2] [Reference Citation Analysis]
89 Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. Journal of Leukocyte Biology 2006;80:1197-213. [DOI: 10.1189/jlb.0506297] [Cited by in Crossref: 182] [Cited by in F6Publishing: 172] [Article Influence: 12.1] [Reference Citation Analysis]
90 Kushida S, Peng B, Uchimura E, Kuang M, Huang L, Miwa M, Ohno T. A tumour vaccine of fixed tumour fragments in a controlled-release vehicle with cytokines for therapy of hepatoma in mice. Digestive and Liver Disease 2004;36:478-85. [DOI: 10.1016/j.dld.2004.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
91 Khatri VP, Shah MH, Petrelli NJ, Li Y, Beckett L, Gibbs JF, Rodriguez-bigas MA. Type-2 dominant cytokine gene expression following hepatic surgery. J Hepatobiliary Pancreat Surg 2006;13:442-9. [DOI: 10.1007/s00534-006-1103-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]